Shubha Jain

St. Michael's Hospital — Canada

Medicine · Health Sciences

11h-index301citations35works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Peripheral Artery Disease Management(15), Venous Thromboembolism Diagnosis and Management(8), Antiplatelet Therapy and Cardiovascular Diseases(7), Angiogenesis and VEGF in Cancer(6), Coronary Interventions and Diagnostics(5)

Publications35 total

Corrigendum to “Angiogenesis-related proteins as biomarkers for peripheral artery disease” [Heliyon Volume 9, Issue 9, September 2023, Article e20166]
Heliyon·2025Open Access
Angiogenesis-related proteins as biomarkers for peripheral artery disease
Heliyon·2023· 10 citedOpen Access
Fatty acid binding protein 4 has prognostic value in peripheral artery disease
Journal of Vascular Surgery·2023· 13 citedOpen Access
Angiogenic Growth Factors and Their Predictive Role in Patients With Peripheral Arterial Disease
Journal of Vascular Surgery·2023
Fatty Acid Binding Protein 4 Has Prognostic Value in Peripheral Artery Disease
Journal of Vascular Surgery·2023· 1 citedOpen Access
The prognostic capability of inflammatory proteins in predicting peripheral artery disease related adverse events
Frontiers in Cardiovascular Medicine·2022· 8 citedOpen Access
Low-dose aspirin and rivaroxaban combination therapy to overcome aspirin non-sensitivity in patients with vascular disease
Frontiers in Cardiovascular Medicine·2022· 9 citedOpen Access
Urinary Cystatin C Has Prognostic Value in Peripheral Artery Disease
Biomolecules·2022· 15 citedOpen Access
Urinary Fatty Acid Binding Protein 3 Has Prognostic Value in Peripheral Artery Disease
Frontiers in Cardiovascular Medicine·2022· 12 citedOpen Access
The Clinical Utility of D-Dimer and Prothrombin Fragment (F1+2) for Peripheral Artery Disease: A Prospective Study
Biomedicines·2022· 3 citedOpen Access
The Clinical Utility of D-Dimer and Prothrombin Fragment (F1+2) for Peripheral Artery Disease: A Prospective Study
SSRN Electronic Journal·2022· 4 citedOpen Access
Platelet Works as a Point-of-Care Test for ASA Non-Sensitivity
Journal of Vascular Surgery·2021Open Access
Plateletworks® as a Point-of-Care Test for ASA Non-Sensitivity
Journal of Personalized Medicine·2021· 3 citedOpen Access
Microfluidic design of tumor vasculature and nanoparticle uptake by cancer cells
Microfluidics and Nanofluidics·2021· 7 cited
Microfluidic Protein Imaging Platform: Study of Tau Protein Aggregation and Alzheimer’s Drug Response
Bioengineering·2020· 3 citedOpen Access
Personalization of Aspirin Therapy Ex Vivo in Patients with Atherosclerosis Using Light Transmission Aggregometry
Diagnostics·2020· 13 citedOpen Access
Ticagrelor as an Alternative Antiplatelet Therapy in Cardiac Patients Non-Sensitive to Aspirin
Medicina·2020· 7 citedOpen Access
Numerical modeling and experimental validation of passive microfluidic mixer designs for biological applications
AIP Advances·2020· 22 citedOpen Access
Fatty Acid Binding Protein 4—A Circulating Protein Associated with Peripheral Arterial Disease in Diabetic Patients
Journal of Clinical Medicine·2020· 17 citedOpen Access
The MicroRNA Profile of Patients With Chronic Limb-threatening Ischemia
Journal of Vascular Surgery·2020· 4 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Mohammad Qadura(23), Rawand Abdin(21), Muzammil H. Syed(17), Abdelrahman Zamzam(16), Hamzah Khan(12), Krishna K. Singh(8), Ben Li(8), Mohammed Al‐Omran(7), Niousha Djahanpour(7), Margaret L. Rand(6), Harikrishnan Narayanan Unni(5), Mark Wheatcroft(4), Niousha Jahanpour(4), Reid C. Gallant(4), Sherri Afxentiou(4), Heyu Ni(3), Sara Arfan(3), Shamini Murugavel(2), Antoinette Bugyei‐Twum(2), Mohamed Adam(2)